HSC82 Antibody

What is HSC82 and why are antibodies against it important in molecular biology research?

HSC82 is a cytoplasmic chaperone of the Hsp90 family in Saccharomyces cerevisiae that plays a crucial role in maintaining proteostasis. It functions as the constitutively expressed isoform of Hsp90 in yeast, expressed at approximately 10-fold higher basal levels than its paralog HSP82 under normal conditions . HSC82 is essential for cell viability when expressed as the only Hsp90 protein and contains acid-rich unstructured regions that promote solubility of chaperone-substrate complexes .

Antibodies against HSC82 are important research tools because they allow scientists to:

• Track the involvement of HSC82 in various cellular processes

• Study Hsp90 chaperone pathways and protein folding mechanisms

• Investigate differences between stress-induced (HSP82) and constitutive (HSC82) chaperone functions

• Examine chaperone-client interactions in various experimental conditions

• Study nucleosome dynamics and chromatin remodeling processes where HSC82 plays a role

What are the differences between HSC82 and HSP82 that researchers should consider when selecting antibodies?

Despite sharing 97% sequence identity, HSC82 and HSP82 exhibit several significant differences that impact antibody selection:

• Expression patterns: HSC82 is constitutively expressed at high levels, while HSP82 is strongly induced under stress conditions .

• Enzymatic activity: HSC82 shows higher ATPase activity than HSP82, with approximately 1.3-fold higher activity at 30°C and 1.6-fold higher activity at 37°C .

• Stress resilience: Yeast expressing HSP82 as the sole Hsp90 grows better under heat shock conditions (42°C) compared to yeast expressing only HSC82 .

• ATP binding affinity:

Researchers should select antibodies that can specifically distinguish between these two highly similar isoforms, particularly if studying their differential roles or if working with conditions where both isoforms are present.

What typical applications can HSC82 antibodies be used for in research settings?

HSC82 antibodies have been successfully employed in various research applications including:

• Western blot analysis: For detection and quantification of HSC82 protein levels in yeast extracts .

• Chromatin immunoprecipitation (ChIP): Modified protocols have been developed for ChIP experiments with antibodies against HSC82 to study its role in nucleosome dynamics .

• Co-immunoprecipitation studies: To isolate HSC82 complexes and identify interacting proteins through methods like affinity capture-MS .

• Analysis of nucleotide-dependent interactions: HSC82 antibodies have been used to study how different nucleotides (ATP, ADP, AMP-PNP) affect the interactions between HSC82 and its co-chaperones .

• Studying chaperone pathway progression: To investigate the role of HSC82 in protein folding pathways and its interactions with other chaperones like Hsp70 (Ssa1/2) .

How can researchers optimize immunoprecipitation protocols for HSC82 to study nucleotide-dependent interactions?

Optimizing immunoprecipitation protocols for HSC82 to study nucleotide-dependent interactions requires careful consideration of several experimental parameters:

• Nucleotide selection and concentration: Different nucleotides affect HSC82 interactions distinctly. For instance, stable Sba1 interaction is observed only with AMP-PNP, while Cpr6 interaction is dramatically increased in the presence of AMP-PNP . Use nucleotides at appropriate concentrations (typically 5 mM final concentration).

• Temperature conditions: Incubate cell lysates with nucleotides at physiologically relevant temperatures. Researchers have successfully used 30°C for 5 minutes to observe nucleotide-dependent interactions .

• Buffer optimization:

  • Use nondenaturing buffers to preserve complex integrity

  • Consider adding an ATP regenerating system (ATP+RS) consisting of 4.5 mg phosphocreatine and 8 units of creatine phosphokinase per ml of yeast lysate when studying ATP-dependent interactions

  • Include protease inhibitors to prevent degradation

• Purification strategy: For His-tagged HSC82, use nickel resin with intermediate concentrations of imidazole (approximately 35 mM) in wash buffers to reduce nonspecific binding while maintaining specific interactions .

• Analysis methods: Use both Coomassie blue staining and immunoblot analysis with antibodies against potential interacting partners (Sti1, Ssa1/2, Sba1, Cpr6) to comprehensively assess interaction patterns .

When studying nucleotide cycling, it's important to note that the ATPase activity of HSC82 (kcat = 1.23 ± 0.10 min⁻¹ at 30°C for 6His-Hsc82) is higher than that of HSP82 (kcat = 0.75 ± 0.06 min⁻¹) , which may influence interpretation of results.

What are the critical considerations when using HSC82 antibodies in chromatin immunoprecipitation (ChIP) experiments?

When conducting ChIP experiments with HSC82 antibodies, researchers should consider several critical factors:

• Protocol modification: Standard ChIP protocols require significant modification for optimal results with HSC82 antibodies. As noted in the literature, "For the ChIP experiments with antibodies against Hsc82 and Ssa1, we used a modified version of the protocol described previously" .

• Crosslinking conditions: HSC82 functions as part of large protein complexes, so optimize formaldehyde crosslinking time and concentration to capture transient interactions without overfixing.

• Sonication parameters: HSC82 is involved in nucleosome dynamics, which requires careful optimization of sonication conditions to generate appropriately sized chromatin fragments while preserving protein complexes.

• Antibody specificity: Given the 97% sequence identity between HSC82 and HSP82, antibody specificity is crucial. Use antibodies raised against unique peptide sequences, such as the C-terminal peptide of HSC82 .

• Controls: Include appropriate controls:

  • Input chromatin (pre-immunoprecipitation)

  • Non-specific IgG control

  • Positive control for known HSC82-associated regions

  • HSC82 knockout control when possible

• Validation: Confirm ChIP efficiency through analysis of known HSC82-associated genomic regions before proceeding to genome-wide studies.

For optimal results, researchers should contact the authors of published HSC82 ChIP studies for detailed protocol specifications, as indicated by statements like "the details of which can be given on request" .

How can researchers distinguish between HSC82 and HSP82 functions using specific antibodies?

Distinguishing between HSC82 and HSP82 functions using antibodies requires strategic experimental approaches:

• Epitope selection: Generate antibodies against unique regions where the 3% sequence divergence occurs between HSC82 and HSP82. C-terminal peptides have been successfully used for HSC82-specific antibodies .

• Validation in knockout strains: Test antibody specificity in strains where either HSC82 or HSP82 has been deleted to confirm selective recognition.

• Differential expression conditions:

  • Under normal conditions, HSC82 is expressed at 10-fold higher levels than HSP82

  • Under heat shock, HSP82 is strongly induced to reach equivalent levels as HSC82

  • Use these differential expression patterns to study isoform-specific functions

• Complementary methodologies: Combine antibody-based detection with genetic approaches:

  • Use strains expressing only HSC82 or HSP82 as the sole source of Hsp90

  • Analyze differential growth patterns (e.g., HSP82-only strains grow better at 42°C)

  • Examine differences in drug sensitivity (e.g., radicicol) between isoforms

• Functional assays: Compare ATPase activities, which differ between the isoforms (HSC82 has ~1.3-fold higher activity at 30°C) , and analyze how these differences impact client protein folding and maturation.

• Client protein specificity: Use antibodies against known client proteins to identify differences in the client range between HSC82 and HSP82, as research indicates they may have evolved to provide "fine-tuned chaperone assistance under physiological and stress conditions" .

What are the recommended approaches for generating custom HSC82 antibodies for research?

Based on successful approaches in the literature, researchers can generate effective HSC82 antibodies through the following methods:

• Epitope selection strategies:

  • C-terminal peptide approach: Generate antibodies against a C-terminal peptide of HSC82, as successfully done by Susan Lindquist's group

  • Recombinant protein approach: Express and purify full-length HSC82 protein for immunization, as demonstrated for the related Ssa1 antibody production

• Expression system for antigen production:

  • Clone the HSC82 gene into an expression vector (e.g., pET15b) to create an N-terminal 6xHIS-fusion protein

  • Express in E. coli strain BL21-CodonPlus(DE3)-RIL or similar expression hosts

  • Optimize growth conditions: grow cells to OD600 of 0.6 at 37°C, induce with 0.5 mM IPTG, and culture for 20h at 17°C to maximize protein production

• Purification protocol:

  • Lyse cells in appropriate buffer (e.g., phosphate buffer with KCl and protease inhibitors)

  • Use French pressure cell for efficient lysis

  • Treat lysate with DNaseI in the presence of MgOAc₂

  • Purify using affinity chromatography (e.g., HIS-Trap column) with an imidazole gradient (6-600 mM)

• Immunization protocol:

  • Use purified protein to immunize rabbits according to standard procedures

  • Follow established immunization schedules with proper boosting intervals

  • Consider using services from specialized facilities like Cocalico Biologicals

• Antibody validation: Validate specificity using western blot analysis in wild-type yeast and strains with HSC82 deleted or mutated to confirm specific recognition.

How can researchers effectively validate the specificity of HSC82 antibodies?

Thorough validation of HSC82 antibodies is critical for ensuring experimental reliability:

• Genetic validation:

  • Test antibodies in strains where HSC82 is deleted or downregulated

  • Compare signal in wild-type strains versus strains expressing mutant versions of HSC82

  • Use strains expressing epitope-tagged HSC82 as positive controls

• Cross-reactivity assessment:

  • Test for cross-reactivity with HSP82 (97% identical to HSC82)

  • Perform parallel Western blots with samples from strains expressing only HSC82 or HSP82

  • Test antibody reactivity across different temperatures and stress conditions where expression levels of HSC82 and HSP82 vary

• Specificity controls in immunoprecipitation:

  • Include controls with non-specific IgG

  • Verify that HSC82 complexes are "specifically retained by nickel resin only in the presence of His-HSC82"

  • Confirm expected co-chaperone interactions (e.g., Sti1, Ssa1/2, Sba1, Cpr6) under appropriate nucleotide conditions

• Peptide competition assays:

  • Pre-incubate antibody with excess immunizing peptide before Western blot or immunoprecipitation

  • Loss of signal confirms specific binding to the target epitope

• Immunoblot analysis optimization:

  • Test different antibody dilutions to determine optimal concentration

  • Evaluate different blocking agents to minimize background

  • Use chemiluminescence detection methods as recommended in published protocols

What protocols have been optimized for studying HSC82 interactions with Hsp70 and other co-chaperones?

The literature describes several optimized protocols for studying HSC82 interactions with co-chaperones:

• Cell lysis and complex isolation:

  • Disrupt cells in the presence of glass beads with eight 30-second pulses

  • For His-tagged HSC82, isolate complexes by incubation with nickel resin (1-1.5 hours with rocking at 4°C)

  • Wash with lysis buffer containing 0.1% Tween 20 and 35 mM imidazole

  • Elute by boiling in SDS-PAGE sample buffer

• Nucleotide-dependent interaction studies:

  • Adjust cell lysate to contain specific nucleotides (5 mM each):

    • AMP-PNP (non-hydrolyzable ATP analog)

    • ATP plus an ATP regenerating system (ATP+RS)

    • ADP

  • Incubate at 30°C for 5 minutes to allow equilibration of nucleotide-dependent interactions

• Analysis of interaction patterns:

  • Separate protein complexes by gel electrophoresis

  • Perform both Coomassie blue staining and immunoblot analysis

  • Use specific antibodies against co-chaperones (Sti1, Ssa1/2, Sba1, Cpr6)

  • Note specific interaction patterns:

    • Sti1 copurifies with HSC82 under all nucleotide conditions

    • Ssa1/2 (Hsp70) recovery is slightly reduced in the presence of ATP

    • Sba1 interaction is observed only with AMP-PNP

    • Cpr6 interaction is dramatically increased with AMP-PNP

• Functional validation:

  • Study the effects of HSC82 mutations on interactions with co-chaperones

  • Analyze ATPase activity modulation by co-chaperones

  • Compare interaction patterns between HSC82 and HSP82 to identify isoform-specific co-chaperone preferences

This optimized methodology has revealed that HSC82 shows distinct nucleotide-dependent interaction patterns with co-chaperones, providing insights into the functional cycling of the Hsp90 chaperone system.

What are common issues researchers encounter when using HSC82 antibodies and how can they be resolved?

Researchers often encounter several challenges when working with HSC82 antibodies:

• Cross-reactivity with HSP82:

  • Issue: Due to 97% sequence identity, many antibodies cross-react with both isoforms.

  • Solution: Use antibodies specifically raised against unique regions (e.g., C-terminal peptides); validate in strains expressing only one isoform; consider using epitope-tagged versions when possible .

• Inconsistent protein retention during purification:

  • Issue: "Mutant forms of His-Hsp82 were inconsistently retained by the nickel resin" .

  • Solution: Focus on the HSC82 isoform for consistent retention; optimize imidazole concentration in wash buffers (approximately 35 mM); ensure complete cell lysis with multiple glass bead disruption cycles .

• Background signal in immunoblots:

  • Issue: High background can obscure specific HSC82 signals.

  • Solution: Optimize blocking conditions; use freshly prepared blocking agents; increase wash steps; dilute antibody appropriately; consider alternative detection methods like chemiluminescence .

• Interference from endogenous nucleotides:

  • Issue: Endogenous nucleotides can affect HSC82 complex formation.

  • Solution: Dialyze lysates to remove endogenous nucleotides before adding specific nucleotides for interaction studies .

• Variable co-chaperone detection:

  • Issue: Some co-chaperones may show weak or inconsistent signals.

  • Solution: Optimize sample preparation for specific co-chaperones; adjust detergent concentrations; consider adding phosphatase inhibitors for phosphorylation-dependent interactions; use nucleotide-specific conditions (e.g., AMP-PNP for Sba1 interaction) .

How do post-translational modifications of HSC82 affect antibody recognition and experimental outcomes?

Post-translational modifications (PTMs) of HSC82 can significantly impact antibody recognition and experimental results:

• Phosphorylation effects:

  • Phosphorylation states can alter epitope accessibility

  • Consider using phosphatase inhibitors in lysis buffers to preserve phosphorylation states

  • For phosphorylation-specific studies, use antibodies against known phosphorylation sites or employ phosphorylation-state-specific antibodies

• Conformational changes:

  • HSC82 undergoes significant conformational changes during its ATPase cycle

  • Different antibodies may preferentially recognize specific conformational states

  • Nucleotide binding (ATP, ADP, AMP-PNP) induces distinct conformations that affect co-chaperone binding and potentially antibody recognition

  • Consider using conformation-specific antibodies for studying specific stages of the chaperone cycle

• Complex formation considerations:

  • HSC82 functions in large multi-protein complexes

  • Antibody epitopes may be masked in certain complexes

  • Different extraction conditions may yield different complexes

  • Use mild detergents (0.1% Tween-20) to preserve complexes while allowing antibody access

• Experimental design implications:

  • Different experimental conditions may yield variable results due to PTM changes

  • Include appropriate controls for each experimental condition

  • Consider using multiple antibodies targeting different epitopes to ensure comprehensive detection

What are the critical factors to consider when comparing HSC82 antibody data from different experimental conditions?

When comparing HSC82 antibody data across different experimental conditions, researchers should consider these critical factors:

• Expression level variations:

  • HSC82 is constitutively expressed at high levels but can be further induced 2-3 fold by heat shock

  • HSP82 is strongly induced under stress conditions, changing the ratio between isoforms

  • Normalize data appropriately to account for expression level changes

• Temperature effects:

  • ATPase activity of HSC82 varies with temperature (higher at 37°C than at 30°C)

  • Temperature affects chaperone-client interactions and complex stability

  • Growth conditions (e.g., 30°C vs. 42°C) significantly affect HSC82 function in vivo

• Nucleotide state considerations:

  • Different nucleotides (ATP, ADP, AMP-PNP) induce distinct HSC82 conformations

  • Co-chaperone interactions vary dramatically depending on nucleotide state:

    • Sba1 interacts with HSC82 only in the presence of AMP-PNP

    • Cpr6 interaction is dramatically increased with AMP-PNP

    • Ssa1/2 (Hsp70) recovery is slightly reduced with ATP

• Strain background variations:

  • When comparing data from different yeast strains, consider genetic background effects

  • In strains expressing only HSC82 or HSP82, compensatory mechanisms may alter normal function

  • Validate findings across multiple strain backgrounds when possible

• Data normalization approaches:

  • Use appropriate loading controls for immunoblot analysis

  • For co-immunoprecipitation studies, normalize co-chaperone signals to the amount of immunoprecipitated HSC82

  • For functional studies, consider normalizing to total protein or cell number

By carefully accounting for these variables, researchers can make valid comparisons between experiments conducted under different conditions and gain meaningful insights into HSC82 function.

How are HSC82 antibodies being used to study the role of molecular chaperones in proteostasis networks?

HSC82 antibodies are playing an increasingly important role in deciphering complex proteostasis networks:

• Client protein identification:

  • HSC82 antibodies enable affinity capture-mass spectrometry approaches to identify the HSC82 "client proteome"

  • Research suggests HSC82 interacts with approximately 20% of the yeast proteome

  • These antibodies help reveal HSC82's preference for targeting intrinsically disordered regions (IDRs) of client proteins

• Chaperone pathway mapping:

  • HSC82 functions downstream of Hsp70 in the chaperone network

  • Antibodies against both chaperones help map the sequential actions of these proteins

  • Studies using these antibodies have revealed that HSC82 "has been suggested to interact with late folding intermediates"

• Stress response dynamics:

  • HSC82 antibodies enable tracking of chaperone network remodeling during stress conditions

  • They help distinguish the roles of constitutive (HSC82) versus stress-inducible (HSP82) chaperones

  • This distinction is crucial for understanding how cells maintain proteostasis during normal growth versus stress conditions

• Isoform-specific functions:

  • HSC82 and HSP82 "differ in their enzymatic properties, resilience to stress and client range"

  • Specific antibodies help researchers determine how these differences contribute to fine-tuned chaperone functions

  • This approach has revealed that the isoforms likely "evolved to provide fine-tuned chaperone assistance under physiological and stress conditions"

• Chromatin dynamics:

  • HSC82 antibodies have revealed unexpected roles in chromatin biology

  • ChIP experiments show HSC82 involvement in "rapid nucleosome removal"

  • This application expands our understanding of chaperone functions beyond protein folding

What role do HSC82 antibodies play in studying nucleosome dynamics and chromatin remodeling?

HSC82 antibodies have revealed unexpected and significant roles for this chaperone in chromatin biology:

• Nucleosome removal studies:

  • HSC82 antibodies used in ChIP experiments have demonstrated that "HSP90/70 chaperones are required for rapid nucleosome removal"

  • These studies have expanded our understanding of molecular chaperones beyond their classical protein folding roles

  • Specialized ChIP protocols have been developed specifically for HSC82 antibodies to study these processes

• Chaperone recruitment to chromatin:

  • Antibodies enable tracking of HSC82 recruitment to specific genomic regions

  • This approach helps identify DNA elements and transcription factors that mediate HSC82 recruitment

  • Studies can reveal temporal dynamics of HSC82 association with chromatin during transcriptional activation

• Interaction with chromatin remodeling machinery:

  • HSC82 antibodies used in co-immunoprecipitation experiments can identify interactions with chromatin remodeling complexes

  • These studies help determine whether HSC82 works cooperatively with or independently of established chromatin remodelers

  • Such information is crucial for building comprehensive models of chromatin dynamics

• Transcription-coupled chaperone function:

  • HSC82 antibodies have been used alongside antibodies against transcription factors (e.g., Gal4) and RNA polymerase II in ChIP experiments

  • This approach helps establish the relationship between transcription and chaperone-mediated nucleosome dynamics

  • It reveals whether HSC82 acts primarily during transcription initiation, elongation, or termination

• Nucleosome assembly versus disassembly:

  • Strategic use of HSC82 antibodies can help distinguish whether this chaperone primarily facilitates nucleosome removal, assembly, or both

  • Kinetic ChIP experiments with these antibodies can determine the temporal order of chaperone recruitment relative to nucleosome dynamics

  • Such studies provide mechanistic insights into chromatin biology

How can researchers use HSC82 antibodies to study the interplay between different chaperone systems?

HSC82 antibodies serve as powerful tools for investigating complex chaperone networks and their coordination:

• HSC82-Hsp70 cooperation studies:

  • HSC82 antibodies, used alongside Hsp70 (Ssa1) antibodies, reveal sequential or concurrent action

  • Immunoprecipitation studies show that "Hsp90 works downstream of Hsp70 and has been suggested to interact with late folding intermediates"

  • These antibodies help quantify the slight reduction in Ssa1/2 recovery with HSC82 in the presence of ATP

• Co-chaperone network mapping:

  • HSC82 antibodies help decipher the complex regulation by various co-chaperones

  • They reveal nucleotide-dependent interactions with specific co-chaperones:

    • Sti1 copurifies with HSC82 under all conditions

    • Sba1 interaction occurs only in the presence of AMP-PNP

    • Cpr6 interaction is dramatically increased with AMP-PNP

• Comparative chaperone system analysis:

  • Combined use of antibodies against different chaperone systems (HSC82, Hsp70, small HSPs) helps determine:

    • Client protein handoff mechanisms

    • Functional redundancy or specialization

    • System-specific responses to different stressors

• Temporal dynamics of chaperone action:

  • Time-course experiments using HSC82 antibodies alongside other chaperone antibodies reveal the sequence of chaperone engagement

  • Such approaches help determine whether different chaperone systems act sequentially or simultaneously

• Stress-specific chaperone network reorganization:

  • HSC82 antibodies enable comparison of chaperone network composition under normal versus stress conditions

  • They help distinguish between constitutive interactions and stress-induced remodeling of chaperone networks

  • This approach has revealed that while "HSC82 is expressed at tenfold higher levels than HSP82" under normal conditions, "heat shock only leads to a moderate induction of HSC82 and a strong induction of HSP82 such that the levels become equal"

Through these applications, HSC82 antibodies contribute significantly to our understanding of the integrated function of cellular chaperone networks in maintaining proteostasis.